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Somitehh) signals are known to pattern the somite into dermomyotomal, myotomal and
sclerotomal cell fates. By employing explants of presomitic mesoderm cultured with constant levels of Wnt3a
conditionedmedium and increasing levels of Shh, we found that differing levels of Shh signaling elicit differing
responses from somitic cells: the lowest level of Shh signaling allows dermomyotomal gene expression,
intermediate levels induce loss of dermomyotomal markers and activation of myogenic differentiation, and
higher levels induce loss of myotomal markers and activation of sclerotomal gene expression. In addition, we
have found that in the presence of high levels of Wnt signaling, instead of inducing sclerotomal markers, Shh
signals act tomaintain the expression of dermomyotomal andmyotomalmarkers. One of the sclerotomal genes
induced by high levels of Shh signaling is Nkx3.2. Forced expression of Nkx3.2 blocks somitic expression of the
dermomyotomal marker Pax3 both in vitro and in vivo. Conversely, forced expression of Pax3 in somites can
block Shh-mediated induction of sclerotomal gene expression and chondrocyte differentiation in vitro. Thus
we propose that varying levels of Shh signaling act in a morphogen-like manner to elicit differing responses
from somitic cells, and that Pax3 and Nkx3.2 set up mutually repressing cell fates that promote either
dermomyotome/myotome or sclerotome differentiation, respectively.
© 2008 Elsevier Inc. All rights reserved.IntroductionIn the vertebrate embryo, somites give rise to multiple tissues
including cartilage, bone and muscle of the vertebral column.
Somites are pairs of spherical structures located adjacent to the
neural tube of the developing embryo. They are formed by periodic
budding from the presomitic mesoderm, the timing of which is a
highly controlled event (Hirsinger et al., 2000; Pourquie, 2004;
Stockdale et al., 2000). A newly formed somite consists of epithelial
cells at the periphery, with a small number of mesenchymal cells in
the center (somitocoele) (Christ et al., 2000). As a somite matures,
the cells within the somite are separated into ventral and dorsal
domains. The sclerotome is formed from cells located in the ventral
domain of the somite, where the once epithelial cells become
mesenchymal. Cartilage and bone of the vertebrae and ribs are
derived from the sclerotome. The dermomyotome is formed in the
dorsal domain of the somite, where the cells remain epithelial. As
somite maturation proceeds, the dermomyotome will give rise to
both the dermis and an interstitial layer of differentiated skeletal
muscle, the myotome (Stockdale et al., 2000).(A.B. Lassar), li.zeng@tufts.edu
l rights reserved.The initial speciﬁcation of the dorsal and ventral somitic cell fates
is vital because it determines the number of precursors that will give
rise to either cartilage, muscle or dermal cells. When a somite ﬁrst
forms, all the epithelial cells in the immature somite have the
potential of adopting a sclerotomal or a dermomyotomal cell fate. In
somite rotation experiments, when a newly formed somite was
rotated 180°, the cells were reprogrammed to become either
sclerotome or dermomyotome based upon their new location
(Aoyama and Asamoto, 1988; Dockter and Ordahl, 2000), indicating
that cell fate had not yet been determined in these newly formed
somites and that local environmental signals induce the appropriate
somitic cell fate. Multiple extracellular signals expressed in the
surrounding tissues determine somite cell fates (Stockdale et al.,
2000). Wnt proteins secreted from the dorsal neural tube (Wnt1 and
Wnt3a) and from the surface ectoderm (Wnt4, Wnt6 and Wnt7a)
promote the formation of the dermomyotome andmyotome (Christ et
al., 1992; Fan et al., 1997; Fan and Tessier-Lavigne, 1994; Geetha-
Loganathan et al., 2006; Geetha-Loganathan et al., 2005; Münsterberg
et al., 1995; Schmidt et al., 2004). Ectopic expression of Wnt proteins
has been noted to induce the expression of both Pax3 and Pax7, which
are expressed throughout the dermomyotome and in proliferative
myogenic precursors that migrate into the myotome (Fan et al., 1997;
Fan and Tessier-Lavigne,1994; Geetha-Loganathan et al., 2006; Otto et
al., 2006; Relaix et al., 2006; Wagner et al., 2000). Furthermore, Wnt
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ing MyoD, Myf5 and Myosin Heavy Chain, in a PKA or PKC-dependent
manner (Brunelli et al., 2007; Chen et al., 2005; Münsterberg et al.,
1995). In addition to inducing the dorsal somite fate, Wnt proteins
have also been documented to inhibit the expression of the
sclerotomal marker Pax1 (Capdevila et al., 1998; Fan et al., 1997; Fan
and Tessier-Lavigne, 1994).
Sonic Hedgehog (Shh), a signaling molecule secreted by both the
notochord and ﬂoor plate of the neural tube, is essential to induce
formation of the sclerotome and cartilage differentiation of ventral
somitic cells (Chiang et al., 1996; Fan et al., 1995; Fan and Tessier-
Lavigne, 1994; Johnson et al., 1994). In the Shh knockout mouse,
sclerotome formation is compromised, and no vertebral column is
formed (Chiang et al., 1996). Similarly, mice lacking all hedgehog
signaling due to a loss of the hedgehog signal transducer smoothened,
fail to express the sclerotomal markers Pax1 and Nkx3.2 (Zhang et al.,
2001). Moreover, gain-of-function studies have demonstrated that
ectopic expression of Shh induced the expression of Pax1 while
inhibiting the expression of the dermomyotomal marker Pax3
(Borycki et al., 1998; Johnson et al., 1994).
Shh also promotes the myotome cell fate (Borycki et al., 1999;
Buttitta et al., 2003; Gustafsson et al., 2002; McDermott et al., 2005;
Münsterberg et al., 1995). Mouse embryos lacking Shh or its receptor
smoothened display markedly decreased Myf5 expression, suggesting
that Shh is essential for muscle formation (Chiang et al., 1996; Zhang
et al., 2001). Several lines of evidence support the idea that
myogenesis in the epaxial (i.e., medial) domain of the myotome
requires the combination of both Shh and Wnt signaling (reviewed in
Bailey et al. 2001). A molecular understanding of how such signals can
synergistically activate Myf5 expression can be explained by the dual
requirement for both TCF and GLI binding sites in the enhancer
element that drives Myf5 expression in the epaxial myotome (Borello
et al., 2006).
Shh signals may promote myotome formation by promoting the
maturation of dermomyotomal cells to become MyoD/Myf5 expres-
sing myotomal cells (Feng et al., 2006; Hammond et al., 2007). In
zebraﬁsh, Shh signaling is necessary for Pax3/7-expressing cells in the
dermomyotome to transition into MyoD-expressing cells; in the
absence of Shh signaling, Pax3 and Pax7-expressing cells in the somite
increase in number but fail to activate the myogenic program (Feng et
al., 2006; Hammond et al., 2007). Therefore, Shh is required for the
differentiation of Pax3/7-expressing dermomyotomal cells into myo-
tomal cells and for the subsequent loss of Pax3/7 gene expression in
these differentiated myocytes. These ﬁndings in zebraﬁsh are
consistent with earlier ﬁndings in chicken embryos which indicate
that ectopic expression of Shh in the somite induced loss of Pax3
expression while promoting premature myogenic differentiation
(Amthor et al., 1999). Thus Shh acts in the somite to drive sclerotome
formation, repress the expression of dermomyotomal gene expres-
sion, and induce the maturation of the dermomyotome into
differentiated myotomal cells.
Prior studies have indicated that the dorsal–ventral identity of
somitic cells is established by both antagonistic and synergistic
activities of Wnt and Shh signals (Fan et al., 1995; Fan and Tessier-
Lavigne, 1994; Münsterberg et al., 1995). Fan and Tessier-Levigne
demonstrated that signaling by cells expressing either Wnt1 or Shh,
when positioned adjacent to somites, is able to travel through the
entire distance of a young somite and that these signaling pathways
can induce mutually exclusive patterns of dermomyotomal or
sclerotomal gene expression, respectively (Fan et al., 1995; Fan and
Tessier-Lavigne, 1994). Thus cells within the somite must interpret
Wnt signals, secreted by both the neural tube and surface ectoderm,
and Shh, secreted by the notochord and ﬂoor plate, to establish dorsal
and ventral somitic ﬁelds with clear borders. However, it is not clear
from these prior studies whether Shh and Wnt act as morphogens to
set up these different cell types, with distinct fates being designatedby differing levels of signaling by these factors. To examine this issue
more thoroughly, we have examined the response of somitic cells to
varying levels of Shh in the presence of constant Wnt signaling. We
ﬁnd that differing levels of Shh elicit differing responses from somitic
cells, with very low levels of Shh working in combination with Wnt
signals to maintain dermomyotomal gene expression, slightly higher
levels inducing both loss of dermomyotomalmarkers and activation of
myogenic differentiation, and yet higher levels inducing the loss of
myotomal markers and the activation of sclerotomal gene expression.
In addition, we have found that in the presence of high levels of Wnt
signaling, instead of inducing sclerotomal markers, Shh acts to
maintain the expression of dermomyotomal and myotomal markers.
Two of the sclerotomal genes induced by high levels of Shh
signaling are Nkx3.2 and Sox9, which are both known to promote
cartilage formation (Lefebvre and Smits, 2005; Murtaugh et al., 2001;
Zeng et al., 2002). Ectopic expression of either Nkx3.2 or Sox9 can
induce ectopic cartilage formation in the chick embryo (Murtaugh et
al., 2001; Zeng et al., 2002). Mice lacking Nkx3.2 (a.k.a., Bapx1) display
a severe reduction of somitic Sox9 expression and defects in axial
cartilage formation, suggesting that Nkx3.2 promotes chondrogenesis
by inducing Sox9 expression (Akazawa et al., 2000; Lettice et al., 1999;
Tribioli and Lufkin, 1999). Sox9 in turn activates the chondrogenic
program by directly activating expression of cartilage-speciﬁc genes
such as collagen II and aggrecan, and Sox9-deﬁcient cells are incapable
of chondrogenic differentiation (Akazawa et al., 2000; Bi et al., 2001;
Lefebvre et al., 1997; Lettice et al., 1999; Sekiya et al., 2000; Tribioli and
Lufkin, 1999). However because both Nkx3.2 and Sox9 are expressed
during early phases of somite patterning prior to cartilage differentia-
tion, it is not clear whether Nkx3.2 and Sox9 act only on a pre-existing
ventral somite population to promote chondrogenesis or possibly also
play an earlier role in demarcating the ventral somite ﬁeld. Consistent
with this latter notion, we have found that ectopic expression of
Nkx3.2 blocks the expression of both dermomyotomal and myotomal
markers in vitro and in vivo. Pax3 is a transcription factor expressed in
the dermomyotome and subsequently in proliferating cells within the
myotome (Tajbakhsh, 2003; Bajard et al., 2006) Relaix, 2005; Relaix,
2006 (Gros et al., 2005) and plays an important role in promoting
muscle differentiation (Maroto et al., 1997; Relaix et al., 2005, 2006).
We have found that forced expression of Pax3 in somites can block
Shh-mediated induction of sclerotomal gene expression and chon-
drocyte differentiation in vitro. Thus we propose that varying levels of
Shh signals act as a morphogen to elicit differing responses from
somitic cells, and that Pax3 and Nkx3.2 set up mutually repressing cell
states that promote either dermomyotome/myotome or sclerotome
differentiation, respectively.
Materials and methods
Materials
White leghorn chicken eggs were obtained from Charles River
Laboratory (Willmington, MA) and Hy-Line International (Elizabeth-
town, PA). Mouse anti-Pax3, anti-Pax7 and anti-Myosin antibodies
were purchased from Developmental Studies Hybridoma Bank. Rabbit
anti-HA and rabbit anti-V5 antibodies were purchased from Sigma.
Rabbit anti-GFP antibody was purchased from Abcam. N-Shh was
produced as described in Zeng et al. (2002). Human BMP4 proteinwas
purchased from R&D.Wnt3a conditioned mediumwas produced from
Wnt3a-secreting cells (ATCC) as instructed. RatB1a control and
RatB1a-Wnt1 cells were gifts from Dr. Jan Kitajewski (Columbia
University). Alkaline phosphatase virus (RCAS (A)-AP) and Pax3 virus
(RCAS (A)-AP) were generated as described in Maroto et al. (1997).
Plasmids for making in situ hybridization probes have been described
before (Reshef et al., 1998; Zeng et al., 2002). For the construction of
RCAS (B)-Sox9V5 plasmid, chicken Sox9 sequence (from PCR) was
cloned into pBluescript-V5 vector (kindly provided by Dr. Tony Ip,
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pBluescript-Sox9V5 was cut with EcoRI and XbaI, and blunt ended,
and subsequently cloned into the RCAS-B viral vector. Electroporation
vector pMES-GFP was kindly provided by Dr. Tom Schultheiss (Beth
Israel Deaconess Medical Center). pMES-Nkx3.2 was generated by PCR
cloning of chicken Nkx3.2 into BamHI cut pMES vector. pMES-Sox9V5
was generated by cloning EcoRI and XbaI cut fragment from pBlue-
script-Sox9V5 into SmaI cut pMES-GFP vector. Nkx3.2 virus was
generated using RCAS (B)-Nkx3.2HA plasmid as described (Murtaugh
et al., 2001). Viruses were produced according to the standard
protocol (Johnson et al., 1994), and were titered by direct visualizing
GFP expression (in the case of RCAS-GFP production) or indirect
immunocytochemistry using anti-HA or anti-V5 antibodies. All viruses
used have reached a titer of 108 particles/ml.
Embryo explant culture and viral infection
Somite explants from chicken embryos of HH stage 10were excised
as described (Zeng et al., 2002). Brieﬂy, chicken embryos were pinned
onto an agar dish with the ventral side up. The embryos were treated
with dispase (Roche, 2 mg/ml) to dissociate the germ layers. Tungsten
needleswere used to dissociate the endoderm layer and to slice out the
mesodermal somite tissues. When culturing the somites with the
surface ectoderm, no dispasewas used. The explantswere incubated in
5 μl concentrated virus stock (titer of 108/ml) for 30 min–1 h on ice
before being transferred onto the collagen gel (Zeng et al., 2002). The
collagen gel was constructed as a lower collagen layer and an upper
collagen layer, with the somite explants in the middle. The composi-
tion of the collagen layers is: 30% rat tail collagen I (BD biosciences) and
1× DMEM. A total of 25 μl of collagen gel mixture was used for each
explant. After the collagen solidiﬁed at room temperature, explants inFig. 1. Shh concentration gradient patterns dorsal–ventral fates of the somite. (A) In the pres
either dorsal or ventral somite markers. Presomitic mesoderm explants were cultured for ﬁv
SHH. Lane 2: 34 ng/ml N-SHH. Lane 3: 67 ng/ml N-SHH. Lane 4: 125 ng/ml N-SHH. Lane 5: 250
Gene expressionwas assayed by RT-PCR. (B) Shh is required tomaintain but not initiate the ex
explants from stage 10 chicken embryos were cultured for either one day (panels 1–4) or
conditioned medium containing 125 ng/ml N-SHH (panels 2 and 6), Wnt3a-conditioned med
N-SHH (panels 4 and 8). Pax3 expression was analyzed by immunocytochemistry and confo
explant. The Dapi images were taken at the same magniﬁcation. Few somitic cells migrat
proliferation and migration. It is evident that more cells were present in Shh-treated explant
explants from stage 10 chicken embryos were cultured for ﬁve days in either control conditio
images of Pax3 expression (panels 1 and 2) and DAPI staining (panels 3 and 4) are displayed.collagen gel were cultured in 400 μl ofα-MEM somite culture medium
(with 10% FBS, 1% penstrep, 5% chick embryo extract, 1 ng/ml bFGF) in
4-well dishes (Nunc) at 37 °C for 1–6 days before being harvested for
either RT-PCR analysis or immunocytochemistry (Holowacz et al.,
2006). Results from Fig. 1 were obtained using only embryos of 11
somites. Co-cultureswith control Rat1B cells or Rat1B-Wnt1 cellswere
performed according to Münsterberg et al. (1995). Brieﬂy, the Rat1B
cells were scraped off tissue culture grade plastic and subsequently
plated onto an agar dish containing medium for 4 h to overnight.
Aggregates of Rat1B cells (which form on agar dishes) were cut into
small pieces and co-cultured together with the presomitic mesoderm
explants in the collagen gel.
RT-PCR analysis
Explants were processed by the RNeasymini kit fromQiagen (Zeng
et al., 2002). Primer sequences have been described before (Reshef et
al., 1998; Zeng et al., 2002). All PCR analyseswere normalized based on
GAPDH expression quantiﬁed by a phospho-imager (BioRad).
Immunocytochemistry
Embryo explants were ﬁxed with 4% paraformaldehyde and
incubated with primary antibodies overnight (Holowacz et al.,
2006). After washing with PBST, they were incubated with secondary
antibodies (conjugated with Alexa 488 (green) or 594 (red) from
Invitrogen) overnight, followed by repeated washing the day after.
Electroporated embryos were serial-sectioned ﬁrst on the cryostat
(10 μm thick, Microm HM560) before immunostaining. The sections
on slides were incubated overnight with primary antibodies, and for
4 h with the secondary antibodies.ence of constant levels of Wnt3a signals, differing levels of Shh are necessary to induce
e days in Wnt3a-conditioned medium and increasing amounts of N-SHH. Lane 1: no N-
ng/ml N-SHH. Lane 6: 500 ng/ml N-SHH. Lane 7: 1 μg/ml N-SHH. Lane 8: 2 μg/ml N-SHH.
pression of Pax3 in presomitic mesoderm exposed toWnt signals. Presomitic mesoderm
ﬁve days (panels 5–8) in either control conditioned medium (panels 1 and 5), control
ium (panels 3 and 7), or the combination ofWnt3a-conditioned medium plus 125 ng/ml
cal microscopy. The inset in each panel represents a whole mount Dapi staining of the
ed out of the explants at day 1. By day 5, the explants were much larger due to cell
s. (C) Wnt3a alone is sufﬁcient to induce Pax3 expression in somite IV–VI. Somite IV–VI
ned medium (panels 1 and 3) or Wnt3a-conditioned medium (panels 2 and 4). Confocal
(D) Model showing differing levels of Shh signal lead to differing cell fates in the somite.
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Whole mount in situ hybridization was performed as described
(Murtaugh et al., 2001). After whole mount in situ, the embryos were
sectioned on the cryostat (Microm HM560) at 10 μm.
Electroporation
For in ovo electroporation, plasmid DNA of 1 μg/ml concentration
was injected into the lumen of the newly formed somites using a
micromanipulator (Parker Picospritzer II), and immediately electro-
porated using the electroporator (BTX ECM830) on chicken HH Stage
14–16 embryos. The electrodes are Genetrodes by Genetronics, model
514. Electroporation conditions are: 30 V, 20 ms pulse length, 5 pulses
with 600 ms intervals. After the operation, the window of the shell
was sealed with scotch tape, and allowed to incubate at 37 °C for
2 days before the embryos were beheaded and ﬁxed for
immunocytochemistry.
Imaging
In situ hybridization and immunocytochemistry were visualized
and photographed on the following microscopes: Olympus IX71
inverted microscope, Nikon Eclipse 800 compound microscope, Leica
MZ16F stereo microscope and Leica TCS SP2 AOBS confocal
microscope.
Results
Shh gradient determines dorsal–ventral somitic cell fates
To determine the effect of varying levels of Shh signaling on the
speciﬁcation of somitic cell fates, we cultured chicken presomitic
mesoderm explants (isolated from stage 10 chicken embryos) with a
constant amount of Wnt3a-conditioned medium and increasing
levels of the N-terminal fragment of Sonic Hedgehog (N-Shh), which
is soluble and a potent Shh agonist (Marti et al., 1995). We employed
Wnt3a-conditioned medium (Willert et al., 2003) in these cultures,
to ensure that each of the explants would receive the same amount
of Wnt3a signal. Following incubation of the explants in increasing
concentrations of N-Shh, we assayed the expression of both dorsal
and ventral somite markers by RT-PCR analysis. We varied the N-Shh
concentration in the culture medium from 34 ng/ml–2 μg/ml. We
believe this level of Shh signaling reﬂects a physiological level of Shh
signal transduction, as downstream markers induced by N-Shh were
expressed at similar levels as in somite explants cultured in the
presence of notochord (a source of endogenous Shh; data not
shown). Our RT-PCR analysis indicated that Patched 2 (Ptc2), a
previously described Hedgehog responsive gene (Pearse et al., 2001),
displayed a gradual increase in expression in response to increasing
levels of N-Shh (Fig. 1A, lanes 1–8). In contrast, the expression of
dermomyotomal and myotomal markers responded to increasing
levels of N-Shh in a complicated and biphasic pattern. While a low
level of N-Shh (34 ng/ml) induced the expression of Pax3 in somitic
explants (Fig. 1A, lane 2), further increasing levels of N-Shh (67 ng/
ml–250 ng/ml) led to a steady decrease of Pax3 expression (Fig. 1A,
lanes 3–6). Consistent with these results, an earlier analysis of
mouse somite explants showed that a low level of Shh at 2.5 nM
(which is equivalent to 35 ng/ml) did not inhibit Pax3 expression,
while higher levels of Shh at 25 nM (equivalent to 350 ng/ml)
inhibited expression of murine Pax3 (Fan et al., 1997). Interestingly,
the loss of Pax3 gene expression induced by increasing levels of N-
Shh correlated with the activation of MyoD and Myf5 at these
intermediate concentrations of N-Shh (67–250 ng/ml) (Fig. 1A, lanes
3–6). While intermediate levels of N-Shh-induced MyoD and Myf5
expression (Fig. 1A, lanes 4–6), concentrations of N-Shh at or above500 ng/ml led to a precipitous loss of both MyoD and Myf5
expression (Fig. 1A, lanes 7–8).
Expression of the sclerotomal markers, Nkx3.2, Sox9 and Pax1,
were induced to maximal levels by a threshold intermediate
concentration of N-Shh (125–500 ng/ml) (Fig. 1A, lanes 3–5).
Induction of Pax1 required greater levels of N-Shh than did either
Nkx3.2 or Sox9 (Fig. 1A, lanes 3–5). These ﬁndings suggest that
sclerotome gene expression requires a threshold level of Shh
signaling, and that the induction of Pax1 requires a higher concentra-
tion of Shh, as compared to that of Nkx3.2 and Sox9. These in vitro
ﬁndings are consistent with the fact that compared to other
sclerotomal markers, Pax1 is only highly expressed in the ventral-
medial domain of the sclerotome, next to the notochord that secretes
Shh, and therefore in the region of the somite exposed to the highest
level of Shh.
We were puzzled by the fact that low levels of N-Shh (when
combined with Wnt3A) induced the expression of Pax3 in somite
explants, as the dermomyotome expression domain of Pax3 is
expanded in mutant mice embryos lacking Shh (Chiang et al., 1996;
Martinelli and Fan, 2007). We considered the possibility that N-Shh
might induce the expansion of a small population of Pax3-positive
cells within the somite, because Shh is known to both induce somitic
cell proliferation and block apoptosis (Borycki et al., 1999; Kruger et
al., 2001; Teillet et al., 1998). To explore this possibility, we cultured
the presomitic mesoderm explants for either one day or ﬁve days in
Wnt3a conditioned medium either in the presence or in the absence
of Shh (125 ng/ml). After only one day of culture, explants treatedwith
either control conditioned medium or with medium containing only
Shh failed to express Pax3 (Fig. 1B, panels 1 and 2). In striking contrast,
after one day of culture Pax3 protein was easily detected in explants
treatedwithWnt3a alone (Fig.1B, panel 3). Addition of N-Shh (125 ng/
ml) did not signiﬁcantly alter the expression level of Pax3 induced by
Wnt3a conditioned medium, possibly because this level of Shh was
not very high (Fig. 1B, panel 4). This ﬁnding is consistent with prior
reports indicating Wnt signaling alone is sufﬁcient to induce Pax3
expression in explants of murine presomitic mesoderm cultured for
24 h (Fan et al., 1997). Furthermore, work in zebraﬁsh employing
mutants in the hedgehog pathway or the hedgehog antagonist,
cyclopamine, indicates that the induction of Pax3 or Pax7 expression
in the dermomyotome of this species does not require hedgehog
signaling (Feng et al., 2006; Hammond et al., 2007). In marked
contrast to explants cultured for only one day, presomitic mesoderm
explants cultured for ﬁve days did not express detectable Pax3 protein
when cultured in Wnt3a conditioned medium alone (Fig. 1B, panel 7).
However, like the one-day cultures, the explants cultured for ﬁve days
in the combination of Wnt3a-conditioned medium and N-Shh
(125 ng/ml) expressed signiﬁcant levels of Pax3 (Fig. 1B, panel 8).
This ﬁnding is consistent with our RT-PCR data shown in Fig. 1A,
where the explants were analyzed after ﬁve days of culture. Thus our
analysis suggests that Shh may be required to maintain Pax3
expression in explants of presomitic mesoderm cultured for ﬁve
days in Wnt3a conditioned medium, although it may not be required
to initiate Pax3 expression in explants cultured for only one day in
Wnt3a conditioned medium. To investigate whether more mature
somites also require exogenous Shh to express Pax3, we cultured
somites IV–VI for ﬁve days in either the absence or presence of Wnt3a
conditionedmedium. In contrast to explants of presomitic mesoderm,
high levels of Pax3 were detectable in explants of somite IV to VI that
had been cultured for ﬁve days in Wnt3a conditioned medium (Fig.
1C). Interestingly, thesemoremature somites behave in vitro as if they
have already been exposed to Shh signals in vivo (Münsterberg et al.,
1995). Therefore, our analyses suggest that lower levels of Shh
signaling act in combination with Wnt signals to promote the
maintenance of Pax3 expression in somites cultured in vitro.
We propose that a gradient of Shh patterns somitic cells to adopt
different cell fates (Fig. 1D). Working in combination with Wnt
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expression of the dermomyotomal marker, Pax3, in vitro, while higher
levels of Shh signaling both repress the expression of Pax3 and induce
the expression of MyoD and Myf5. Greater levels of Shh signaling
repress the expression of myotomal markers while allowing the
continued expression of sclerotomal makers, which are apparently
activated by a threshold level of Shh signaling. These in vitro ﬁndings
are consistent with the in vivo expression patterns for Pax3, Myf5,Fig. 2. In situ hybridization analysis of Pax3, Nkx3.2 and Sox9. (A)Whole mount in situ hybrid
mark the caudal to rostral levels of the somitic mesoderm. a, presomitic mesoderm (Psm). b,
various axial levels. Panels 1–4, Pax3 expression. Panels 5–8, Nkx3.2 expression. Panels 9–12,
12. Sections at somite I level are shown in panels 3, 7 and 11. Sections at somite III level areMyoD, Nkx3.2, Sox9 and Pax1, which are expressed in progressively
more ventralized somitic domains, respectively (Fig. 1D).
Comparison of somitic expression of Pax3, Nkx3.2 and Sox9
Our RT-PCR results led us to hypothesize that a relatively low
concentration of N-Shh (as low as 67 ng/ml) can induce factors that
antagonize Pax3 expression. As Sox9 and Nkx3.2 were induced byization analysis of Pax3, Nkx3.2 and Sox9 on 12 somite (stage 10) chick embryos. Arrows
somite I. c, somite III. d, somite V. (B) Sections of Pax3, Nkx3.2 and Sox9 ISH embryos at
Sox9 expression. Sections at the presomitic mesoderm level are shown in panels 4, 8 and
shown in panels 2, 6 and 7. Sections at somite V level are shown in panels 1, 5 and 9.
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Pax3 (Fig. 1A, lanes 3 and 4), we considered the possibility that either
Sox9 or Nkx3.2 may act to repress the expression of Pax3. To
determine if Sox9 and Nkx3.2 are inhibitors of Pax3 expression, we
ﬁrst directly compared their expression with that of Pax3 during the
period when the dorsal–ventral somite domains are determined.
Whole mount in situ hybridization analysis of stage 10 chicken
embryos revealed that Pax3 is expressed in the dorsal neural tube,
throughout the rostral presomitic (-I somite) mesoderm and in dorsal
regions of more mature somites (Figs. 2A and B). In the ﬁrst somite,
Pax3 is expressed throughout the somite, with higher levels of
expression in the dorsal domain; as the somite matures, Pax3
expression is gradually restricted to the dorsal domain (Otto et al.,
2006; Schubert et al., 2001; Williams and Ordahl, 1994). In contrast toFig. 3. Nkx3.2 and Sox9 inhibit Wnt3a-induced Pax3 expression in somite explants. (A) So
encoded Nkx3.2HA, Sox9V5 or GFP. Somite IV–VI explants of stage 10 chicken embryos wer
explant, arrows indicating a cell that expressed GFP as well as Pax3. Panels 5–8, RCAS-B-Nkx3
a cell that expressed Sox9V5 as well as Pax3. The inset within each panel shows a low power
view of virus-expression (GFP, Nkx3.2 and Sox9) and Pax3. Dapi images are not overlaid w
signiﬁcant changes in cell numbers in these explants were observed. (B) Quantiﬁcation of th
For each virus-infected sample, a total number of 500–1000 virus-infected cells from at least
(C) Somite explants immunostained for collagen II expression following infectionwith retrov
condition as described in panel A. Panels 1–4, RCAS-B-GFP-infected explant. Panels 5–8, RCA
GFP, Nkx3.2HA and Sox9V5. Red, collagen II. Overlay, merged view of virus-expression (GFP, N
view of each explant. (D) Nkx3.2 virus-infected cells do not adopt a cartilage fate in the presen
VI of stage 10 chicken embryos were cultured in either Wnt3a-conditioned medium (panels 1
L-cell conditioned medium plus 100 ng/ml BMP4 protein (panels 9–12). The explants were cu
Red, collagen II. Overlay, merged view of virus-expression (GFP, Nkx3.2 and Sox9), collagenPax3, Nkx3.2 expression is absent from the presomitic mesoderm, but
is strongly expressed in the ventral region of somite III as well as in the
somitocoele (Figs. 2A and B, panels 5–8). Interestingly, the loss of Pax3
expression from the ventral region of somite III correlates with the
induction of Nkx3.2 expression in this somitic domain (Fig. 2B,
compare panels 2 and 6). Unlike Pax3 and Nkx3.2, Sox9 exhibits a
more dynamic expression pattern during somite maturation. Sox9 is
initially expressed throughout the presomitic mesoderm before the
budding of the ﬁrst somite; its expression largely diminishes in the
next two somites and only begins to reappear starting from the third
somite in the anterior ventral domain (Figs. 2A and B, panels 9–12).
Sox9 is strongly expressed in the ventral region of more mature
somites (somite V–VII) (Figs. 2A, and B, panel 9). Our expression
analyses indicate that dermomyotomal and sclerotomal genemite explants immunostained for Pax3 expression following infection with retroviral
e cultured in Wnt3a conditioned medium for 5 days. Panels 1–4, RCAS-B-GFP-infected
.2HA-infected explant. Panels 9–12, RCAS-B-Sox9V5-infected explant, arrows indicating
ed view of each explant. Green: GFP, Nkx3.2HA and Sox9V5. Red, Pax3. Overlay, merged
ith virus and Pax3 images so that yellow overlapping expression is more evident. No
e results of panel A. Percentage of virus-infected cells that express Pax3 was quantiﬁed.
5 different views were analyzed under the microscope. Standard deviations are shown.
irally encoded Nkx3.2HA, Sox9V5 or GFP. Somite explants were cultured under the same
S-B-Nkx3.2HA-infected explant. Panels 9–12, RCAS-B-Sox9V5-infected explant. Green:
kx3.2 and Sox9), collagen II and Dapi. The inset within each panel shows a low powered
ce ofWnt3a, but do express collagen II in the presence of exogenous BMP4. Somites IV–
–4), Wnt3a-conditioned medium plus 100 ng/ml BMP4 protein (panels 5–8), or control
ltured altogether for 6 days before immunostaining. Green: GFP, Nkx3.2HA and Sox9V5.
II and Dapi. The inset within each panel shows a low powered view of each explant.
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the morphological changes indicative of a differentiated dermomyo-
tome and myotome. The restriction of Pax3 expression to the dorsal
somite correlates with the induction of Nkx3.2 in the ventral region of
the newly formed somite. In contrast, Sox9 expression is not yet
expressed at high levels in the ventral domain of the somite until well
after Pax3 expression is already restricted to the dorsal somite and
Nkx3.2 is strongly expressed in the ventral somitic domain. These
dynamic expression patterns raise the possibility that the induction of
Nkx3.2 in the ventral somite may act to both inhibit Pax3 expression
and augment that of Sox9 in this region of the somite.
Nkx3.2 and Sox9 inhibit Wnt3a-induced Pax3 expression
To explore whether Nkx3.2 or Sox9 has the potential to directly or
indirectly repress the expression of dermomyotomal genes in the
ventral somite, we examined the effect of retrovirally-expressed
Nkx3.2 and Sox9 on the expression of a dorsal marker, Pax3, in
isolated somites. In the embryo, Pax3 expression is induced by Wnt
proteins secreted by either the neural tube (Wnt1, Wnt3a) or the
surface ectoderm (Wnt4, Wnt6 and Wnt7a) (Fan et al., 1997; Otto et
al., 2006; Reshef et al., 1998; Wagner et al., 2000). Consistent with
these prior observations, culture of somites IV–VI from stage 10 chick
embryos, which behave as if they have already seen a Shh signal in
vivo (Münsterberg et al., 1995), expressed robust levels of Pax3 in
response to Wnt3a conditioned medium alone (Fig. 1C). Thus, we
investigated whether the expression of retroviral encoded Nkx3.2 or
Sox9 would blunt the ability of Wnt3a conditioned medium to induce
the expression of Pax3 in such cultured somites. Robust expression of
Pax3 (red) was induced by Wnt3a conditioned medium in somite
explants infected with a control virus encoding GFP (RCAS-GFP) (Fig.
3A, panels 1–4). Extensive overlap was found between GFP and Pax3
expression, indicating that ectopic GFP expression does not inhibit
Pax3 expression. In contrast, similarly cultured somites infectedwith a
retrovirus encoding HA-tagged Nkx3.2 (RCAS-Nkx3.2HA) displayed
markedly reduced Pax3 expression (Fig. 3A, panels 5–8). Indeed,
almost no Nkx3.2HA-expressing cells (green) expressed Pax3 (red),
suggesting that forced Nkx3.2 expression strongly inhibits Pax3
expression in somitic cells (Fig. 3A, panels 5–8). While somites
infected with a retrovirus encoding V5-tagged Sox9 (RCAS-Sox9V5)
still expressed Pax3, the majority of cells that expressed viral Sox9V5
did not express Pax3 (Fig. 3A, panels 9–12). Some of the Sox9V5-
expressing cells appear to form clusters that are devoid of Pax3
expression (Fig. 3A, panels 9–12). It is possible that ectopic Sox9
expression has converted these cells into proliferating cartilage cells
(see below) (Zeng et al., 2002).
We quantiﬁed this immunostaining result by calculating the
percentage of virus-expressing cells that were Pax3-positive (Fig.
3B). In GFP-infected explants, 89% of the GFP-expressing cells were
Pax3-positive. In contrast, only 1% of the Nkx3.2-expressing cells were
Pax3-positive, indicating that ectopic Nkx3.2 strongly inhibits the
expression of Pax3 induced by Wnt3a. In RCAS-Sox9V5 infected
explants, only 38% of the Sox9-expressing cells were Pax3-positive,
suggesting that ectopic Sox9 represses, but does not completely
inhibit, Wnt3a-induced Pax3 expression (Fig. 3B). Because virally
encoded Sox9 is known to activate expression of endogenous Nkx3.2
in infected somites (Zeng et al., 2002), it is possible that the reduced
level of Pax3 expression observed in RCAS-Sox9V5 infected cells
reﬂects the induction of Nkx3.2 in these cultures.
As prior work has established that forced expression of either
Nkx3.2 or Sox9 can activate chondrogenesis in somite explants
cultured in medium containing BMPs (Murtaugh et al., 2001), we
investigated whether somites cultured inWnt3a conditionedmedium
and infected with either RCAS-Nkx3.2HA or RCAS-Sox9V5 have
similarly adopted a cartilage cell fate. To assay for chondrocyte
differentiation, we evaluated collagen II expression in these explantsvia immunocytochemistry. While neither RCAS-GFP-infected cells nor
RCAS-Nkx3.2HA-infected cells expressed any collagen II (Fig. 3C,
panels 1–8), RCAS-Sox9V5-infected cells were all collagen II-positive
(Fig. 3C, panels 9–12). This ﬁnding suggests that ectopic expression of
Nkx3.2 is not sufﬁcient to activate the chondrocyte differentiation
program in somites cultured in Wnt conditioned medium, while
expression of ectopic Sox9 is able to activate this differentiation
program in similarly cultured cells.
It is possible that RCAS-Nkx3.2-infected cells did not adopt a
cartilage fate due to an insufﬁcient amount of BMP in the medium, as
prior work has indicated that Nkx3.2 requires a higher amount of
BMP4 than does Sox9 to induce chondrogenesis (Zeng et al., 2002). To
examine if Nkx3.2 failed to induce collagen II expression due to an
insufﬁcient amount of BMP in the culture medium, we administered
exogenous BMP4 to RCAS-Nkx3.2HA-infected somites exposed to
Wnt3a conditionedmedium. In the presence of both exogenous BMP4
and Wnt3a conditioned medium, RCAS-Nkx3.2HA infected cells still
failed to express any detectable collagen II (Fig. 3D, panels 5–8). In
contrast, RCAS-Nkx3.2 infected somites cultured in the presence of
exogenous BMP4 and in the absence of Wnt3a conditioned medium
expressed detectable levels of collagen II (Fig. 3D, panels 9–12). These
ﬁndings indicate thatWnt3a conditionedmedium blocks the ability of
Nkx3.2 to induce cartilage formation even in the presence of
exogenous BMP4.
Nkx3.2, but not Sox9, inhibits surface ectoderm-induced Pax3 expression
As Pax3 expression in the somite is strongly induced by signals
from the surface ectoderm, we examined the effects of exogenous
Nkx3.2 and Sox9 on the induction of Pax3 by signals from this tissue
(Brunelli et al., 2007; Reshef et al., 1998). Culture of somites IV–VI (but
not somites I–III) with the adjacent surface ectoderm induces the
expression of Pax3 in such explants (Reshef et al., 1998). We thus
infected explants of somites IV–VI cultured with the adjacent surface
ectoderm with either RCAS-GFP, RCAS-Nkx3.2HA or RCAS-Sox9V5.
While we observed extensive overlapping expression of GFP (green)
and Pax3 (red) (Fig. 4A, panels 1–4) in the RCAS-GFP-infected
explants, very few of the RCAS-Nkx3.2HA-infected explants expressed
Pax3 (Fig. 4A, panels 5–8). Unlike RCAS-Nkx3.2HA-infected explants,
explants infected with RCAS-Sox9V5 exhibited robust Pax3 expres-
sion, and many of the Sox9V5 positive cells were also Pax3 positive
(Fig. 4A, panels 9–12), indicating that ectopic Sox9 does not inhibit the
expression of Pax3 induced by the surface ectoderm. Quantiﬁcation of
the immunostaining result described above indicated that 96% of the
GFP-infected cells expressed Pax3, while only 4% of the Nkx3.2HA-
expressing cells were Pax3-positive, and 70% of cells that expressed
Sox9V5 were Pax3-positive (Fig. 4B). Therefore, our results indicate
that ectopic Nkx3.2 expression efﬁciently inhibits Pax3 expression
induced by signals from the surface ectoderm as compared to ectopic
Sox9 expression, which only slightly dampens Pax3 expression in
these same cultures.
We determined whether ectopic expression of either Nkx3.2 or
Sox9 was able to drive cartilage differentiation of somites cultured
with adjacent surface ectoderm. While we were unable to detect
expression of the cartilage-speciﬁc marker collagen II in somite/
ectoderm explants infected with RCAS-GFP (Fig. 4C, panels 1–4),
explants infected with RCAS-Nkx3.2HA occasionally exhibited low
levels of collagen II expression (in less than 1% of the infected cells)
(arrows, Fig. 4C, panels 5–8). In contrast, explants infected with RCAS-
Sox9V5 robustly expressed collagen II (Fig. 4C, panels 9–12). In the
presence of exogenous BMP4, however, RCAS-Nkx3.2HA induced a
signiﬁcant amount of collagen II expression in somite/ectoderm
explants (Fig. 4D, panels 5–8), conﬁrming again that Nkx3.2 requires
BMP signaling to induce chondrogenesis (Zeng et al., 2002). Taken
together, our ﬁndings indicate that ectopic Nkx3.2 blocks the
induction of Pax3 by either soluble Wnt3A or signals from the surface
Fig. 4. Effects of Nkx3.2 and Sox9 on surface-ectoderm-induced Pax3 expression. (A) Pax3 expression in somite/ectoderm explants infected with GFP, Nkx3.2HA and Sox9V5. Stage 10
chicken embryo explants of somite IV–VI with surface ectoderm attached were cultured for 5 days. Panels 1–4, RCAS-B-GFP-infected explant. Panels 5–8, RCAS-B-Nkx3.2HA-infected
explant. Panels 9–12, RCAS-B-Sox9V5-infected explant. The inset within each panel shows a low powered view of each explant. Arrows indicating cells that expressed GFP or Sox9V5
as well as Pax3. The inset within each panel shows a low powered view of each explant. Green: GFP, Nkx3.2HA and Sox9V5. Red, Pax3. Overlay, merged view of virus-expression (GFP,
Nkx3.2 and Sox9) and Pax3. Dapi images are not overlaid with virus and Pax3 images so that yellow overlapping expression is more evident. No signiﬁcant changes in cell numbers in
these explants were observed. (B) Quantiﬁcation of the results of panel A. Percentage of virus-infected cells that express Pax3 was quantiﬁed. For each virus-infected sample, a total
number of 500–1000 virus-infected cells from 5 different views were analyzed under the microscope. (C) Somite/ectoderm explants immunostained for collagen II expression
following infection with retrovirally encoded Nkx3.2HA, Sox9V5 or GFP. Somite explants were cultured under the same condition as described in Panel A. Panels 1–4, RCAS-B-GFP-
infected explant. Panels 5–8, RCAS-B-Nkx3.2HA-infected explant. Arrow, an Nkx3.2HA-expressing cell that also expresses a low level of collagen II. Panels 9–12, RCAS-B-Sox9V5-
infected explant. Green: GFP, Nkx3.2HA and Sox9V5. Red, collagen II. Overlay, merged view of virus-expression (GFP, Nkx3.2 and Sox9), collagen II and Dapi. The inset within each
panel shows a low powered view of each explant. (D) Nkx3.2 virus-infected cells adopt a cartilage fate in the presence of exogenous BMP4. Stage 10 chicken embryo explants of
somite IV–VI with surface ectoderm attached were cultured for 6 days in either control medium (panels 1–4) or in medium supplementedwith 100 ng/ml BMP4 protein (panels 5–8).
The inset within each panel shows a low powered view of each explant. Nkx3.2HA, green. Collagen II, red. Dapi, blue. Overlay, merged image of Nkx3.2HA, collagen II and Dapi.
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mediated repression of Pax3 expression is therefore similar to the
loss of Pax3 expression in the ventral domain of the newly formed
somite, which occurs well before chondrogenesis takes place in these
same cells. In contrast, Sox9, which efﬁciently induces collagen II
expression does not block Pax3 expression.
Ectopic Nkx3.2 inhibits the expression of dermomyotomal markers
in vivo
Our in vitro ﬁndings with somite explants indicate that Nkx3.2 can
efﬁciently inhibit the expression of Pax3 in response to either Wnt3a
or signals from the dorsal ectoderm; in contrast, Sox9 can decrease but
not block the expression of this dorsal somite marker. To evaluate
whether ectopic expression of Nkx3.2 can similarly block expression
of dorsal somitic markers in vivo, we electroporated Nkx3.2 into thedorsal somite cells of chick embryos via in ovo electroporation. Nkx3.2
was cloned into the electroporation vector pMES, which includes an
IRES-GFP module that enables GFP to be co-expressed in the same
cells as Nkx3.2 (James and Schultheiss, 2003; Krull, 2004). pMES-
Nkx3.2 was subsequently electroporated into the dorsal cells of newly
formed somites in stage 13 to 15 chicken embryos. To conﬁrm ectopic
Nkx3.2 expression in dorsal somite cells following electroporation of
pMES-Nkx3.2, we performed whole mount in situ hybridization (ISH)
analysis using an Nkx3.2 RNA probe. Transverse sections of these
electroporated embryos revealed that endogenous Nkx3.2 was
expressed in ventral somite cells and that exogenous Nkx3.2 was
expressed in dorsal somite cells (Fig. 5A). For comparison, we also
electroporated a Sox9-encoding plasmid (pMES-Sox9V5) into the
newly formed somites. To conﬁrm the ectopic expression of Sox9 in
the dorsal somite cells, we performed immunocytochemistry employ-
ing an anti-V5 antibody. Indeed, the epithelial cells in the dorsal lateral
Fig. 5. Nkx3.2, but not Sox9, inhibits the expression of Pax3 and Pax7 in ovo. (A) Ectopic expression of Nkx3.2 in the dorsal somite cells. In situ hybridization (ISH) analysis of chicken
embryos electroporated with pMES-Nkx3.2-GFP into the lumen of the newly formed somites two days after electroporation, using an Nkx3.2 RNA probe. 5 embryos were analyzed
and all exhibited ectopic Nkx3.2 in the dorsal somitic cells. Left panel: whole mount ISH; right panel: a cross section of the whole mount ISH embryo. Arrows: exogenous Nkx3.2
expression. Arrowheads: endogenous Nkx3.2 expression. (B) Ectopic expression of Sox9 in the dorsal somite cells. Immunocytochemistry analysis on sectioned embryos
electroporated with pMES-Sox9-GFP two days after electroporation. 5 sections were analyzed and all cells that expressed GFP also expressed Sox9V5. Panel 1, V5 staining showing
Sox9V5 expression in dorsal somite cells. A bright ﬁeld view of the sectionwas overlaid on the ﬂuorescent image. Panel 2, magniﬁed view of Sox9V5-positive cells. Panel 3, magniﬁed
view of GFP-positive cells. Panel 4, merged image (yellow) of Sox9V5 and GFP. (C) Nkx3.2, but not Sox9, inhibited Pax3 and Pax7 expression. Embryos electroporated with either
pMES-GFP (vector), pMES-Nkx3.2-GFP or pMES-Sox9V5-GFP into the lumen of the newly formed somites were whole mount ﬁxed and serial-sectioned. The sections were
immunostained with antibodies against Pax3 and Pax7. Cells harboring the introduced DNA are GFP-positive, and thus are green. Only overlaid images are shown. Most of the cells
that expressed the introduced plasmids were laterally located. However, the few medially-targeted cells exhibit the same phenotype as these laterally located cells. Panels 1–4, GFP
electroporated embryos (panels 1–2 are 10× views, and panels 3–4 are 40× views). Panels 5–8, Nkx3.2 electroporated embryos (panels 5–6 are 10× views, and panels 7–8 are 40×
views). Panels 9–12, Sox9V5 electroporated embryos (panels 9–10 are 10× views, panels 11–12 are 40× views). Arrows: cells that express introduced DNA (GFP-positive), but are not
Pax3 or Pax7-positive (red). Arrowheads: cells that express introduced DNA (GFP-positive), and are also Pax3 or Pax7-positive (red), and are thus yellow. (D) Quantiﬁcation of the
results of panel C. Percentage of electroporated cells that express Pax3 and Pax7was quantiﬁed. For each electroporated sample, a total number of 100–200 targeted cells from at least
3 embryos were analyzed under the confocal microscope. Only the target cells (GFP-positive) that were located in the normal Pax3 and Pax7 expression domains were used for
counting. Pax3, blue. Pax7, orange. (E) Nkx3.2 induced the expression of Sox9 in the dorsal somite cells. Embryos electroporated with pMES-Nkx3.2-GFP into the lumen of the newly
formed somites were subjected to whole mount in situ hybridization and sectioning, using a Sox9 RNA probe. 5 embryos were analyzed. Panel 1, in situ hybridization of Sox9.
Arrowhead: exogenous Sox9 expression. Arrow: endogenous Sox9 expression. A bright ﬁeld view of the section was overlaid on the ﬂuorescent image. Panel 2, Anti-GFP staining
indicating the ectopic expression of the introduced DNA pMES-Nkx3.2-GFP (arrow). Panel 3, Overlay of the bright ﬁeld ISH imagewith the GFP immunostaining image (arrow). Panel
4, merged bright ﬁeld image of ISH and immunoﬂuorescent staining of endogenous Pax3, showing ectopic Sox9 expression within the Pax3-expressing domain.
160 D.M. Cairns et al. / Developmental Biology 323 (2008) 152–165domain of the somite expressed ectopic Sox9V5 (red), and were also
GFP-positive (green) (Fig. 5B). Therefore, both Nkx3.2 and Sox9 were
targeted to the dorsal somite cells, and our immunocytochemistry
result reassured us that we could use GFP expression to identify cells
co-expressing either ectopic Nkx3.2 or Sox9 plus GFP.
To determine the effects of ectopic Nkx3.2 on dorsal somitic gene
expression, we evaluated the expression of dermomyotomal markers
Pax3 and Pax7 (Relaix et al., 2006). We observed disrupted expression
of Pax3 and Pax7 in the dermomyotome following ectopic expression
of Nkx3.2 (Fig. 5C, panels 5–6). We are conﬁdent that ectopic Nkx3.2
was targeted into the dorsal Pax3 and Pax7-positive cell population,
because Nkx3.2-expressing cells lie dorsal to the myosin-positivemyotome cells (data not shown). Examination at higher magniﬁcation
indicated that dorsal cells expressing Nkx3.2 (green) no longer
expressed Pax3 and Pax7 (red) (Fig. 5C, panels 7–8). In contrast,
Pax3 and Pax7 expression were not perturbed in the dermomyotome
of embryos electroporatedwith either GFP or Sox9 expression vehicles
(Fig. 5C, panels 1–4 and 9–12). Thus ectopic expression of Nkx3.2 was
able to inhibit the expression of Pax3 and Pax7 in vivo, suggesting that
Nkx3.2 prevents the adoption of dorsal somitic cell fates in vivo.
Quantiﬁcation of the immunostaining result following in ovo electro-
poration indicated that in cells electroporated with GFP alone, 76%
expressed Pax3 and 80% expressed Pax7 (Fig. 5D). In contrast, in cells
electroporated with Nkx3.2, only 3% expressed Pax3 and only 7%
161D.M. Cairns et al. / Developmental Biology 323 (2008) 152–165expressed Pax7. In cells electroporated with Sox9V5, 51% expressed
Pax3 and 66% expressed Pax7 (Fig. 5D). Therefore, these in vivo results
are consistent with our in vitro studies and together indicate that
ectopic expression of Nkx3.2, but not Sox9, efﬁciently inhibits
expression of both Pax3 and Pax7.
In addition, we evaluated whether ectopic expression of Nkx3.2 in
the dorsal somite promotes these cells to adopt a ventral cell fate by
examining the expression of the sclerotomal marker, Sox9. Following
electroporation of Nkx3.2 into the dorsal somite, we observed
expression of endogenous Sox9 around the notochord and in the
neural tube and in addition, noted ectopic expression of Sox9 in dorsal
somitic cells, indicating that Nkx3.2 had reprogrammed these dorsal
cells to adopt a ventral cell fate (Fig. 5E, arrow). In summary, we have
found that in vivo expression of Nkx3.2 in dorsal somitic cells strongly
inhibited expression of Pax3 and Pax7, and induced ectopic Sox9
expression.
High level of Wnt signaling inhibits Hedgehog-induced Nkx3.2
expression
Our ﬁndings indicate that forced expression of Nkx3.2 can repress
the expression of the dermomyotomal markers Pax3 and Pax7 in
vitro and in vivo. Therefore, in order for the somite to differentiate
normally, Nkx3.2 expression has to be excluded from the dorsal
domain. Since prior reports have indicated that Wnt proteins could
inhibit the expression of the sclerotome marker Pax1 (Capdevila et
al., 1998; Fan et al., 1997; Fan and Tessier-Lavigne, 1994), we
investigated whether Wnt signals would similarly inhibit Nkx3.2
expression. Because in the presence of Wnt3a conditioned medium,
Shh is still able to induce Nkx3.2 expression in cultured presomitic
mesoderm (Fig. 1A), we suspected that the Wnt signals in such
conditioned medium may not be long-lived enough or of sufﬁcient
intensity to block sclerotomal gene expression. Therefore, to examine
whether high levels of Wnt signaling could inhibit Nkx3.2 expression
induced by Shh, we surrounded explants of presomitic mesoderm
with aggregates of Wnt1-expressing cells and added soluble N-ShhFig. 6. High level of Wnt signaling and Pax3 expression inhibit Nkx3.2 expression. (A) High l
RatB1a cells secretingWnt1 were co-cultured with presomitic mesoderm explants of stage 10
days culture for RT-PCR analysis of indicated genes. Lane 1, control RatB1a cells co-culturedw
presomitic mesoderm explants. Lane 3, control RatB1a cells co-culturedwith presomitic meso
co-cultured with presomitic mesoderm explants in the presence of 250 ng/ml N-SHH. (B) F
induced by N-SHH. Presomitic mesoderm explants were infectedwith avian retroviruses enco
all cultures. Explants were harvested after 5 days culture for RT-PCR analysis of indicated ge
explants.(125 ng/ml) to the cultures simultaneously. The explants were
harvested after ﬁve days of culturing. As observed previously, Wnt
signals alone failed to induce the expression of either dermomyoto-
mal (i.e., Pax3) or myotomal (i.e., MyoD and Myf5) markers in
presomitic mesoderm explants cultured for ﬁve days (Fig. 6A, lane 2).
Intermediate level of Shh signal alone (125 ng/ml) also failed to
induce Pax3, Myf5 and MyoD, but strongly induced the expression of
Nkx3.2 (Fig. 6A, lane 3). In striking contrast, the combination of Shh
and high levels of Wnt signals led to robust expression of Pax3, Myf5
and MyoD, and simultaneously inhibited the expression of Nkx3.2
(Fig. 6A, lane 4), demonstrating that Wnt signals inhibit the
expression of Nkx3.2. Interestingly, we observed that co-culture of
presomitic mesoderm with Wnt1-expressing cells did not blunt the
induction of Patched2, indicating that Wnt signals did not attenuate
the expression of all Shh responsive genes in these cultures (Fig. 6A,
lane 4).
We speculate that the co-expression of Pax3, MyoD, and Myf5 in
these cultures (Fig. 6A, lane 4, as well as Fig. 1A, lane 4) likely reﬂects a
differential exposure of the somitic cells on the surface of the somite
versus those in the interior of the somite to either Wnt, Shh, or both
signals whichmanifests itself as a combination of cell fate responses to
different levels of these signals. While this experimental set up does
not allow for the equal exposure of all somitic cells to the same levels
of Wnt/Shh signaling, it does mimic the in vivo situation, in which
different somitic domains are differentially exposed to different levels
of Wnt and Shh signals, and therefore adopt different fates. In
summary, these results suggest that a high level of Wnt signals (from
both dorsal neural tube and surface ectoderm) promote Shh-mediated
expression of both dermomyotomal and myotomal markers at the
expense of the sclerotomal marker Nkx3.2, and would thus act to
restrict Nkx3.2 expression to the ventral domain of the somite. These
ﬁndings are consistent with and extend prior work which has
indicated that Wnt and Shh signals can act antagonistically to induce
dermomyotomal (Pax3) versus sclerotomal (Pax1) gene expression,
respectively (Borycki et al., 1998; Fan et al., 1995; Fan and Tessier-
Lavigne, 1994; Johnson et al., 1994).evel of Wnt signaling inhibits Nkx3.2 expression and promotes dorsal somite cell fates.
chicken embryos in the presence or absence of N-SHH. Explants were harvested after 5
ith presomitic mesoderm explants. Lane 2,Wnt1-secreting RatB1a cells co-culturedwith
derm explants in the presence of 250 ng/ml N-SHH. Lane 4,Wnt1-secreting RatB1a cells
orced expression of Pax3 inhibits the expression of Nkx3.2 and chondrogenic markers
ding either Pax3 or Alkaline phosphatase (AP, control). 500 ng/ml N-SHHwas present in
nes. Lanes 1 and 3, RCAS-A-AP-infected explants. Lanes 2 and 4, RCAS-A-Pax3-infected
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and chondrogenesis
As discussed above, surrounding presomitic mesoderm with
aggregates of Wnt1-expressing cells biases the response of the
presomitic cells to Shh signals to promote Pax3 expression at the
expense of the sclerotomalmarkerNkx3.2. Because Pax3 is sufﬁcient to
induce myogenesis in somites (Maroto et al., 1997), we wondered
whether the continuous expression of Pax3 was acting to simulta-
neously repress Shh-mediated induction of Nkx3.2 and other scler-
otomal markers. To examine this issue, we infected presomitic
mesodermwith either Pax3 virus (RCAS-Pax3) or control virus alkaline
phosphatase (RCAS-AP). We subsequently challenged these infected
explants to activate sclerotomal/chondrocyte differentiation markers
by the addition of N-Shh (250 ng/ml). As noted previously (Maroto et
al.,1997), infectionof presomiticmesodermwithRCAS-Pax3 efﬁciently
activated the expression of MyoD (Fig. 6B, lanes 2 and 4). While N-Shh
induced the expression of both sclerotomal markers (i.e., Nkx3.2 and
Sox9) and cartilage differentiation markers (i.e., aggrecan, epiphycan
and collagen IX) in RCAS-AP-infected cultures (Fig. 6B, lanes 1 and 3),
the expression of both sclerotomal and cartilage markers were
markedly repressed in the RCAS-Pax3-infected explants (Fig. 6B,
lanes 2 and 4). In contrast, the expressions of Patched2 and Pax1 in
these cultures were either not affected or only slightly dampened by
the expression of exogenous Pax3 (Fig. 6B, compare lanes 1 and 2, and
lanes 3 and 4), suggesting that the effects of Pax3 were not due to
attenuated Hedgehog signal transduction per se. These ﬁndings
indicate that forced expression of Pax3 can both repress N-Shh-
mediated induction of a subset of sclerotomal markers (Nkx3.2 and
Sox9) and block cartilage differentiation of presomitic mesoderm. The
ability of forced Pax3 expression to block both sclerotome induction
and cartilage differentiation is consistent with our ﬁndings that high
levels of Wnt signaling (plus N-Shh) can both promote stable
expression of Pax3 and similarly repress the induction of the
sclerotomal marker Nkx3.2 (Fig. 6A).
Discussion
Shh acts in a morphogen-like manner to pattern dorsal–ventral cell fates
in the somite
Our work suggests that a Shh gradient determines the dorsal–
ventral pattern of cell fates within the somite (Fig. 7). In the presence
of a constant amount of Wnt signals, increasing levels of Shh induce a
graded response in somitic cells; low levels of Shh promote the
expression of the dermomyotomalmarker Pax3, intermediate levels of
Shh induce Myf5 and MyoD expression with a concomitant loss of
Pax3 expression, and higher levels of Shh inhibit the expression ofFig. 7. A gradient of Shh patterns the somite into mutually repressing muscle and cartilage ce
signals. Medium levels of Shh, along withWnt signals, promote the expression of the myotom
factors Nkx3.2, Sox9 and Pax1, and simultaneously repress expression of both dermomyoto
adopt either a dermomyotomal or sclerotomal cell fate. While Pax3 induces the expression
chondrogenesis.dermomyotomal/myotomal markers while promoting the expression
of sclerotomal markers. Superimposed on this graded response to Shh
signals, our ﬁndings also suggest that the relative level of Wnt
signaling can modify the response of somitic cells to Shh signals; with
high levels of Wnt signaling acting to repress the induction of
sclerotomal genes while promoting the induction of both dermomyo-
tomal and myotomal gene expression. Our work suggests that a Shh
concentration gradient works in a morphogen-like fashion to
differentially pattern dorsal–ventral somitic fates. A morphogen is
deﬁned as a signaling molecule that acts directly on a cohort of
equivalent cells to elicit speciﬁc responses depending on its
concentration (Gurdon and Bourillot, 2001). Our in vitro analysis of
somites cultured for several days in constant levels of soluble Wnt3a
plus increasing levels of Shh has demonstrated that increasing
thresholds of Shh sequentially promote dermomyotomal, myotomal
and sclerotomal gene expression. Because our analysis of gene
expression was performed after 5 days in culture it is possible that
differing levels of Shh canmodulate either the induction/maintenance
of differential gene expression in these cultures or the differential
survival/proliferation of distinct cell types. Indeed we noted that low
levels of Shh are apparently not necessary for Wnt-mediated
induction of Pax3, but only for the maintenance of Pax3 expression
in these cultures. Prior work has indicated that a gradient of Shh
protein is deposited within the developing somite (Gritli-Linde et al.,
2001), and that mouse embryos that lack Smoothened, the receptor
for hedgehog signaling, failed to express the sclerotomal markers Pax1
and Nkx3.2 and exhibited much reduced expression of the myotomal
marker Myf5, suggesting that Shh acts directly on somitic cells to
specify their cell fates (Zhang et al., 2001). Since Shh diffuses
throughout the somite (Fan et al., 1995; Fan and Tessier-Lavigne,
1994) and acts directly on these cells, we propose that Shh acts in a
morphogen-like fashion to specify different somitic cell fates by either
inducing or maintaining the expression of dermomyotomal, myoto-
mal and sclerotomal genes at relatively greater levels of Shh signaling,
respectively. Indeed this is similar to the established role for Shh in
patterning cell fates in the ventral neural tube (Ericson et al., 1996;
Roelink et al., 1995; Tanabe et al., 1995).
We were surprised to ﬁnd that low levels (as low as 34 ng/ml) of
Shh promoted Pax3 expression in the presomitic mesoderm in our
long-term cultures (ﬁve days), even though Wnt signals alone were
sufﬁcient to induce the expression of Pax3 in somites cultured for only
one day. In contrast to this apparent in vitro requirement for Shh
signals to maintain somitic Pax3 expression, both Shh null mice
embryos or chicken embryos with early notochord ablation display an
expansion of Pax3 expression (Borycki et al., 1999; Chiang et al., 1996;
Dietrich et al., 1997), suggesting that Shh negatively regulates Pax3
expression in the dermomyotome. In addition, loss of Hedgehog
signaling in zebraﬁsh embryos resulted in an overproduction of Pax3/ll fates. Low levels of Shh promote the maintenance of Pax3 expression induced byWnt
al factors Myf5 andMyoD. High levels of Shh promote the expression of the sclerotomal
mal and myotomal markers. Mutual repression by Pax3 and Nkx3.2 ensures that cells
of MyoD/Myf5 and promotes somitic myogenesis, Nkx3.2 and Sox9 promote somitic
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2006; Hammond et al., 2007), again suggesting that hedgehog signals
are required to restrict the expression of these dermomyotomal Pax
genes. In light of these in vivo ﬁndings, we suggest that the signals
required to initiate versus maintain the expression of Pax3 may be
distinct and that Shh signals may only be necessary to maintain either
the expression of Pax3 or the survival and expansion of Pax3
expressing cells in explants of presomitic mesoderm that lack other
signals that perform such functions in vivo. Indeed it is possible that
Shh signals act to maintain the viability of Pax3 expressing presomitic
mesodermal cells cultured in vitro, as is apparently the case for both
myotomal cells (Borycki et al., 1999) and hypaxial limbmuscle (Kruger
et al., 2001) in vivo.
In the presence ofWnt3a conditionedmedium, intermediate levels
of Shh (67–250 ng/ml), induced the loss of Pax3 expression
concomitant with the induction of MyoD and Myf5. This ﬁnding is
very reminiscent of the requirement for hedgehog signals to induce
the differentiation of Pax3/Pax7-positive dermomyotomal cells in
zebraﬁsh (Feng et al., 2006; Hammond et al., 2007). Indeed,
morpholino-based knockdown of MyoD and Myf5 in zebraﬁsh is
sufﬁcient to enhance the expression of Pax3/7 (Hammond et al.,
2007), indicating that these myogenic regulatory factors (MRFs) are
necessary to repress the expression of these dermomyotomal Pax
genes. Our ﬁnding that intermediate levels of Shh simultaneously
promote the induction of MRFs and the loss of Pax3 expression is
completely consistent with both these recent reports in zebraﬁsh and
with earlier ﬁndings in the chick indicating that ectopic Shh signals
promote premature skeletal muscle differentiation of dermomyoto-
mal cells (Amthor et al., 1999). A clear focus for the future will be to
clarify the details of how hedgehog signaling leads to MRF induction
in Pax3/7 expressing dermomyotomal cells and how the induction of
MRFs leads to a reciprocal down-regulation of Pax3/7 expression.
Intermediate levels of N-Shh, in addition to inducing the activation of
MRF expression in somites cultured in Wnt3a conditioned medium,
also induced the expression of sclerotomal markers in these cultures.
While we were unable to address whether the same or different cells
express sclerotomal versus myotomal markers in these cultures (due
to the absence of good antibodies against chick sclerotomal markers),
we think it is most likely that somitic cells in these cultures express
only one program of gene expression and not both simultaneously
(discussed below).
Finally, high levels of Shh (greater than 500 ng/ml of N-Shh) led to
the loss of all dermomyotomal and myotomal markers in presomitic
mesoderm cultured in the presence of Wnt3a conditionedmedium. In
concert with the loss of all dermomyotomal and myotomal marker
expression at these relatively high concentrations of Shh, expression
of the sclerotomal markers Pax1, Nkx3.2 and Sox9 were maintained at
these levels of Shh signaling. Prior to this work, Münsterberg et al
demonstrated that increasing N-Shh concentrations up to 200 ng/ml
promoted the expression of both MyoD and Pax1 in cultured chick
somites (Münsterberg et al., 1995). Our work is consistent with that
report, and we have observed that even higher concentrations of Shh
can act to repress MyoD gene expression while continuing to induce
that of sclerotomal markers. Our ﬁnding is also consistent with in ovo
notochord implantation in chick embryos (Dietrich et al., 1997). In
such a study, heterotopic grafting of a notochord between the neural
tube and the dorsal somite only inducedMyoD expression in cells that
were located a short distance away from the implant (Dietrich et al.,
1997). In addition to noting a graded response of dermomyotomal,
myotomal and sclerotomal markers to differing levels of Shh, we also
observed that expression of various sclerotomal markers displayed a
requirement for differing threshold levels of Shh. Expression of Pax1
was induced by a higher concentration of Shh as compared to that of
Nkx3.2 and Sox9. Indeed, prior work has indicated that induction of
the sclerotomal markers Pax1 and Twist1 in cultured mouse somites
required different levels of Shh (Fan et al., 1995). A requirement forhigher levels of Shh to induce Pax1 expression (compared to Nkx3.2
and Sox9) is consistent with the localized expression of Pax1 to the
medial-ventral domain within the sclerotome, as compared to other
sclerotome markers which are expressed more laterally (Christ et al.,
2004; Johnson et al., 1994).
Nkx3.2 and Pax3 induce mutually repressive somitic cell fates
Somites are divided into dorsal and ventral domains with clear
borders marked by differential gene expression, even before the
morphological distinction of dermomyotome and sclerotome (see Fig.
2). Importantly, the expression of the dermomyotomal marker Pax3 is
initially expressed throughout the dorsal–ventral extent of the
presomitic mesoderm and its expression is extinguished in the ventral
somite in response to Shh (Borycki et al., 1999; Chiang et al., 1996)
concomitant with the activation of Nkx3.2 in this somitic domain (this
work). In contrast, Sox9 and Pax3 are transiently co-expressed in the
presomitic mesoderm throughout the dorsal–ventral axis. We have
found that forced expression of the Shh-induced transcriptional
repressor, Nkx3.2, can block the expression of Pax3 induced by either
Wnt3a or signals from the surface ectoderm in explanted chicken
somites without inducing cartilage differentiation in such cells.
Furthermore, we have found that ectopic expression of Nkx3.2 in
the dorsal somite was capable of inhibiting Pax3 and Pax7 expression
in vivo. In contrast, forced expression of Sox9, which induced robust
chondrocyte differentiation of somites, attenuated but did not
efﬁciently inhibit Pax3 gene expression induced by either Wnt3a
conditioned medium or signals from the surface ectoderm. These
ﬁndings are consistent with the expression proﬁle of Sox9 and Nkx3.2
in the embryo, and suggest that Shh restricts the expression of
dermomyotomal genes such as Pax3 and Pax7 in part by inducing the
expression of Nkx3.2 in the ventral somite (Murtaugh et al., 2001).
Forced Nkx3.2 expression can block the induction of dermomyo-
tomal markers by Wnt signals without inducing cartilage differentia-
tion in somites. The absence of cartilage differentiation in such
explants may be a consequence of a Wnt-mediated repression of Sox9
gene expression (Day et al., 2005; Hill et al., 2005; Long, 2008; Rodda
and McMahon, 2006). In prior work, we demonstrated that ectopic
Nkx3.2 induces the expression of Sox9 in somites cultured in the
absence of exogenous Wnt signals (Zeng et al., 2002). Apparently,
Wnt3a prevents Nkx3.2 from inducing collagen II expression (this
work) perhaps by promoting β-catenin-mediated Sox9 degradation
(Akiyama et al., 2004). In contrast, Wnt3a did not block chondrogen-
esis in RCAS-Sox9-infected explants, as exogenous Sox9 may be
present at high enough levels to overcome this degradation.
Furthermore, we showed that Nkx3.2 requires a higher level of
BMP4 to promote chondrogenesis (this work and Zeng, 2002). Thus,
our ﬁndings suggest that induction of a ventral somitic cell fate by
Nkx3.2 consists of two steps: (1) in the presence of high levels of Wnt
signals, and a low level of BMP4, Nkx3.2 represses dorsal somite gene
expression (i.e. Pax3) in the absence of inducing cartilage differentia-
tion, and (2) in the absence of Wnt signaling and the presence of a
higher level of BMP4, Nkx3.2 induces the chondrocyte differentiation
program.
We and others have reported that Sox9 expression in the somite is
induced by Sonic hedgehog (Shh) (Buttitta et al., 2003; Zeng et al.,
2002). Although it is known that Shh acts through Gli proteins to
induce Sox9 expression, it was not clear how this takes place. Our past
work indicated that Nkx3.2, which is downstream of Pax1 and likely
Gli proteins (Buttitta et al., 2003; Rodrigo et al., 2003), induced Sox9
expression in whole somite explants. However, our RT-PCR analysis
did not exclude the possibility that Nkx3.2 selectively ampliﬁes a
population of ventral somitic sclerotomal precursor cells (Zeng et al.,
2002). In our current work, we found that ectopic Nkx3.2 expression
in the dorsal somite cells was able to induce Sox9 expression while
repressing Pax3 and Pax7 expression. Therefore, our ﬁndings strongly
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cartilage progenitors in the embryo. This notion is consistent with a
study in 10T1/2 cells, which suggested that Nkx3.2 promotes the
expression of Sox9 during the chondrogenic differentiation of these
cells (Lengner et al., 2005), and is also consistent with observations in
Nkx3.2 null mouse embryos, where reduced Sox9 expression was
observed (Tribioli and Lufkin, 1999).
While Nkx3.2 knockout mice embryos displayed reduced expres-
sion of Sox9 in the sclerotome, it is not known whether expression of
dorsal somite markers such as Pax3 or Pax7 is found in more ventral
positions in such animals (Akazawa et al., 2000; Lettice et al., 1999;
Tribioli and Lufkin, 1999). Gene expression analysis in mice embryos
lacking both Nkx3.2 and the closely related gene, Nkx3.1 (which is also
transiently expressed in the sclerotome (Herbrand et al., 2002; Tanaka
et al., 1999)), revealed that the expression of Myf5 is still restricted to
the myotomal region in the developing somites of these mutant
embryos and is not expressed in the ventral-most somitic domain in
the combined absence of Nkx3.2 and Nkx3.1 (data not shown, L.Z., A. B.
L., and Hans Arnold). Thus, it seems likely that other Shh-induced
factors in addition to Nkx3.2 may also restrict expression of
dermomyotomal and myotomal markers to the dorsal somite.
Consistentwith this idea, it has been reported that theWnt-antagonist,
Sfrp2, is also induced by Shh in the sclerotome and can prevent Wnt1
or Wnt4 from inducing Pax3 expression in mouse somites (Lee et al.,
2000). In the chick, Sfrp2 has been reported to be expressed in the
dermomyotome (Ladher et al., 2000), in the sclerotome (Lin et al.,
2007), or in different somite compartments in different developmental
stages (Terry et al., 2000), while Sfrp1 is expressed in the ventral
somite (Terry et al., 2000). Thus, it is possible that Shh-mediated
induction of Nkx3.2 and Sfrps in the sclerotome may act in parallel to
block Wnt-mediated induction of dermomyotomal and myotomal
markers in ventral regions of the somite.
Co-culture of somites with Wnt1-producing cells alters the
response of somitic cells to Shh signals, promoting expression of the
dermomyotomal/myotomal genes Pax3 and Myf5, and repressing the
induction of Nkx3.2 and other sclerotomalmarkers (see also Capdevila
et al., 1998; Fan et al., 1997; Fan and Tessier-Lavigne, 1994). Pax3 plays
an essential role in somitic myogenesis, where it activates the
expression of myogenic markers MyoD and Myf5 as well as FGF
signaling (Brunelli et al., 2007; Buckingham and Relaix, 2007; Lagha et
al., 2008; Maroto et al., 1997). Pax3 mutant embryos exhibit loss of
muscle progenitors in the epaxial and hypaxial dermomyotome and
fail to form limb muscle (Relaix et al., 2005, 2006). We found that
forced expression of the dermomyotomal marker Pax3 both promoted
myogenesis and blocked Shh-induced expression of both Nkx3.2 and
other markers of cartilage differentiation. While RT-PCR analysis of
such cultures did not exclude the possibility that ectopic Pax3 induced
a clonal expansion of muscle precursors in such somite explants,
genetic evidence has indicated that the combined loss of both Pax3
and its homolog Pax7 resulted in either the apoptosis of dermomyo-
tomal cells or the re-speciﬁcation of these cells into collagen II-
expressing cartilage cells (Relaix et al., 2006). Thus, we propose that
the stable expression of Pax3 or Pax7 results in the commitment of
somitic cells to the dermomyotomal/myotomal cell fate and precludes
the induction of both sclerotomal markers (Sox9 and Nkx3.2) and
cartilage differentiation of these cells in response to Shh signals.
Conversely, our results indicate that forced expression of Nkx3.2
induces a cell state that is incompatible with dermomyotomal/
myotomal gene expression. Thus the stable induction of either Pax3/
Pax7 or Nkx3.2 induce mutually repressing cell states that exclude the
co-expression of both dermomyotomal/myotomal and sclerotomal
markers in the same cell, and thereby ensures that somitic cells
eventually become committed to give rise to either dermomyotomal/
myotomal or sclerotomal derivatives but not both (Fig. 7). A similar
logic has apparently been employed to pattern the neural tube, where
dorsally restricted Pax genes and ventrally restricted Nkx familymembers bothmutually inhibit one another's expression and promote
either distinct dorsal or ventral neural tube cell fates, respectively
(Briscoe et al., 2000).
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